Stock listing
KRX:095700 Genexine, Inc. (제넥신) 주가
Follow Genexine, Inc. into a list and get an email when it puts out news.
Share price · KRX:095700
₩1,776.00 KRW -30.00 (-1.7%)
Close on Nov 20, 2026
- Day range
- ₩1,758.00 – ₩1,875.00 KRWNov 20, 2026
- Volume
- 77,703 sharesNov 20, 2026
- Market cap
- ₩80.77B KRWAt the close on Nov 20, 2026 · price × 45.48M shares outstanding
- 52-week range
- ₩1,758.00 – ₩7,490.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩1.21B KRWMedian day 119,063 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:095700 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩1,776.00 | -30.00 | -1.7% | ₩1,875.00 | ₩1,875.00 | ₩1,758.00 | 77,703 | |
| ₩1,806.00 | -80.00 | -4.2% | ₩1,886.00 | ₩1,924.00 | ₩1,805.00 | 114,046 | |
| ₩1,886.00 | -9.00 | -0.5% | ₩1,893.00 | ₩1,924.00 | ₩1,830.00 | 53,217 | |
| ₩1,895.00 | -68.00 | -3.5% | ₩2,015.00 | ₩2,020.00 | ₩1,881.00 | 128,781 | |
| ₩1,963.00 | -77.00 | -3.8% | ₩2,040.00 | ₩2,060.00 | ₩1,961.00 | 169,504 | |
| ₩2,040.00 | -30.00 | -1.4% | ₩2,070.00 | ₩2,085.00 | ₩2,000.00 | 58,309 | |
| ₩2,070.00 | +55.00 | +2.7% | ₩2,050.00 | ₩2,080.00 | ₩2,000.00 | 85,866 | |
| ₩2,015.00 | +27.00 | +1.4% | ₩2,040.00 | ₩2,060.00 | ₩1,995.00 | 88,509 | |
| ₩1,988.00 | -52.00 | -2.5% | ₩2,000.00 | ₩2,090.00 | ₩1,988.00 | 87,323 | |
| ₩2,040.00 | -30.00 | -1.4% | ₩2,055.00 | ₩2,070.00 | ₩1,983.00 | 96,525 | |
| ₩2,070.00 | +15.00 | +0.7% | ₩2,090.00 | ₩2,105.00 | ₩1,992.00 | 85,603 | |
| ₩2,055.00 | -5.00 | -0.2% | ₩2,100.00 | ₩2,100.00 | ₩1,991.00 | 143,301 | |
| ₩2,060.00 | -80.00 | -3.7% | ₩2,145.00 | ₩2,175.00 | ₩2,030.00 | 101,290 | |
| ₩2,140.00 | -20.00 | -0.9% | ₩2,105.00 | ₩2,185.00 | ₩2,105.00 | 92,912 | |
| ₩2,160.00 | -5.00 | -0.2% | ₩2,215.00 | ₩2,215.00 | ₩2,130.00 | 145,820 | |
| ₩2,165.00 | -85.00 | -3.8% | ₩2,265.00 | ₩2,265.00 | ₩2,165.00 | 82,317 | |
| ₩2,250.00 | -75.00 | -3.2% | ₩2,325.00 | ₩2,355.00 | ₩2,220.00 | 189,004 | |
| ₩2,325.00 | -60.00 | -2.5% | ₩2,355.00 | ₩2,425.00 | ₩2,300.00 | 113,459 | |
| ₩2,385.00 | -55.00 | -2.3% | ₩2,440.00 | ₩2,440.00 | ₩2,320.00 | 69,361 | |
| ₩2,440.00 | -20.00 | -0.8% | ₩2,455.00 | ₩2,455.00 | ₩2,350.00 | 97,974 | |
| ₩2,460.00 | -80.00 | -3.1% | ₩2,585.00 | ₩2,585.00 | ₩2,460.00 | 105,879 | |
| ₩2,540.00 | -60.00 | -2.3% | ₩2,670.00 | ₩2,670.00 | ₩2,535.00 | 98,260 | |
| ₩2,600.00 | -25.00 | -1.0% | ₩2,600.00 | ₩2,660.00 | ₩2,555.00 | 71,941 | |
| ₩2,625.00 | -20.00 | -0.8% | ₩2,695.00 | ₩2,695.00 | ₩2,515.00 | 74,066 | |
| ₩2,645.00 | +65.00 | +2.5% | ₩2,580.00 | ₩2,685.00 | ₩2,580.00 | 79,051 | |
| ₩2,580.00 | -110.00 | -4.1% | ₩2,585.00 | ₩2,675.00 | ₩2,510.00 | 186,558 | |
| ₩2,690.00 | -50.00 | -1.8% | ₩2,760.00 | ₩2,820.00 | ₩2,665.00 | 118,273 | |
| ₩2,740.00 | -35.00 | -1.3% | ₩2,740.00 | ₩2,800.00 | ₩2,640.00 | 144,732 | |
| ₩2,775.00 | -130.00 | -4.5% | ₩2,980.00 | ₩2,980.00 | ₩2,770.00 | 141,400 | |
| ₩2,905.00 | -110.00 | -3.6% | ₩3,005.00 | ₩3,015.00 | ₩2,900.00 | 182,019 | |
| ₩3,015.00 | +180.00 | +6.3% | ₩2,985.00 | ₩3,625.00 | ₩2,980.00 | 2,089,786 | |
| ₩2,835.00 | +65.00 | +2.3% | ₩2,815.00 | ₩2,850.00 | ₩2,760.00 | 76,301 | |
| ₩2,770.00 | -35.00 | -1.2% | ₩2,805.00 | ₩2,875.00 | ₩2,750.00 | 85,263 | |
| ₩2,805.00 | +85.00 | +3.1% | ₩2,700.00 | ₩2,810.00 | ₩2,700.00 | 121,310 | |
| ₩2,720.00 | +45.00 | +1.7% | ₩2,710.00 | ₩2,775.00 | ₩2,675.00 | 64,329 | |
| ₩2,675.00 | -95.00 | -3.4% | ₩2,770.00 | ₩2,770.00 | ₩2,640.00 | 105,428 | |
| ₩2,770.00 | +35.00 | +1.3% | ₩2,740.00 | ₩2,845.00 | ₩2,740.00 | 195,805 | |
| ₩2,735.00 | +10.00 | +0.4% | ₩2,730.00 | ₩2,775.00 | ₩2,700.00 | 113,839 | |
| ₩2,725.00 | -265.00 | -8.9% | ₩2,975.00 | ₩2,990.00 | ₩2,680.00 | 439,623 | |
| ₩2,990.00 | +90.00 | +3.1% | ₩2,895.00 | ₩3,045.00 | ₩2,800.00 | 223,674 | |
| ₩2,900.00 | +65.00 | +2.3% | ₩2,920.00 | ₩2,920.00 | ₩2,775.00 | 192,278 | |
| ₩2,835.00 | +40.00 | +1.4% | ₩2,800.00 | ₩2,870.00 | ₩2,775.00 | 66,861 | |
| ₩2,795.00 | -10.00 | -0.4% | ₩2,800.00 | ₩2,810.00 | ₩2,720.00 | 89,293 | |
| ₩2,805.00 | +15.00 | +0.5% | ₩2,865.00 | ₩2,905.00 | ₩2,800.00 | 91,163 | |
| ₩2,790.00 | -45.00 | -1.6% | ₩2,835.00 | ₩2,895.00 | ₩2,720.00 | 112,257 | |
| ₩2,835.00 | -55.00 | -1.9% | ₩2,900.00 | ₩2,900.00 | ₩2,815.00 | 101,847 | |
| ₩2,890.00 | -70.00 | -2.4% | ₩2,980.00 | ₩2,980.00 | ₩2,860.00 | 163,964 | |
| ₩2,960.00 | 0.00 | 0.0% | ₩3,020.00 | ₩3,020.00 | ₩2,870.00 | 119,853 | |
| ₩2,960.00 | -95.00 | -3.1% | ₩3,055.00 | ₩3,055.00 | ₩2,905.00 | 353,349 | |
| ₩3,055.00 | +35.00 | +1.2% | ₩3,020.00 | ₩3,155.00 | ₩2,960.00 | 301,263 | |
| ₩3,020.00 | -240.00 | -7.4% | ₩3,290.00 | ₩3,320.00 | ₩3,005.00 | 622,684 | |
| ₩3,260.00 | +445.00 | +15.8% | ₩2,845.00 | ₩3,630.00 | ₩2,735.00 | 3,331,659 | |
| ₩2,815.00 | -195.00 | -6.5% | ₩3,030.00 | ₩3,030.00 | ₩2,812.00 | 351,736 | |
| ₩3,010.00 | +365.00 | +13.8% | ₩2,735.00 | ₩3,260.00 | ₩2,640.00 | 1,341,470 | |
| ₩2,645.00 | -90.00 | -3.3% | ₩2,740.00 | ₩2,740.00 | ₩2,545.00 | 221,151 | |
| ₩2,735.00 | -20.00 | -0.7% | ₩2,760.00 | ₩2,800.00 | ₩2,720.00 | 164,089 | |
| ₩2,755.00 | -195.00 | -6.6% | ₩2,910.00 | ₩2,920.00 | ₩2,730.00 | 401,198 | |
| ₩2,950.00 | +100.00 | +3.5% | ₩2,920.00 | ₩3,025.00 | ₩2,840.00 | 322,078 | |
| ₩2,850.00 | -300.00 | -9.5% | ₩3,150.00 | ₩3,160.00 | ₩2,735.00 | 561,520 | |
| ₩3,150.00 | -175.00 | -5.3% | ₩3,325.00 | ₩3,555.00 | ₩3,070.00 | 918,612 | |
| ₩3,325.00 | +325.00 | +10.8% | ₩3,055.00 | ₩3,880.00 | ₩2,870.00 | 5,293,631 | |
| ₩3,000.00 | +520.00 | +21.0% | ₩3,100.00 | ₩3,220.00 | ₩2,795.00 | 3,250,742 |
Splits
3 splits since 2016 · KRX:095700 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 13-for-10 | Split | |
| 106-for-99 | Split | |
| 2-for-1 | Split |
- Ticker
- KRX:095700
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news
Genexine, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 1 in the last 12 months · 1 in all · newest Sep 15, 2026 · oldest 2026
- Decks
- 1 deck · latest January 2023
Valuation
EV/sales 12.0× against a median of 4.9×: 6th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩59.51B KRW
- P/E
- Loss
- EV/sales
- 12.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.4×
- Gross margin
- −24.9%
- Operating margin
- −798.0%
- Net margin
- −650.0%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Genexine, Inc. · KRX:095700 | US$60.01M | US$44.21M | n/a | 12.0× | n/a | 0.4× | −650.0% | 0.0× | n/a |
| Neumora Therapeutics, Inc. · NASDAQ:NMRA | US$63.01M | US$30.65M | n/a | 1,916× | n/a | 3.4× | n/a | 2.9× | 1.07 |
| Poolbeg Pharma PLC · LSE:POLB | US$61.42M | US$55.12M | n/a | n/a | n/a | 7.0× | n/a | 0.0× | n/a |
| vTv Therapeutics Inc. · NASDAQ:VTVT | US$61.33M | −US$15.84M | n/a | −0.4× | n/a | 0.9× | −20.8% | 0.0× | 1.28 |
| Oncopeptides AB · OMXSTO:ONCO | US$61.25M | US$59.05M | n/a | 6.3× | n/a | 25.1× | −223.6% | 5.4× | n/a |
| ViGenCell, Inc. · KRX:308080 | US$61.07M | US$44.61M | n/a | 65.1× | n/a | 2.1× | n/a | 0.2× | n/a |
| HemoGenyx Pharmaceuticals PLC · LSE:HEMO | US$60.45M | US$56.88M | n/a | n/a | n/a | 10.7× | n/a | 0.4× | n/a |
| GlycoNex, Inc. · TPEX:4168 | US$59.91M | US$57.19M | n/a | 84.9× | n/a | 2.3× | n/a | 0.6× | n/a |
| ISU Abxis Co., Ltd. · KRX:086890 | US$59.84M | US$42.28M | n/a | 1.1× | n/a | 0.7× | −16.0% | 0.0× | n/a |
| Rani Therapeutics Holdings, Inc. · NASDAQ:RANI | US$58.99M | US$16.85M | n/a | 2.6× | n/a | 1.7× | −493.0% | 0.1× | 2.21 |
| HeXun Biosciences Co Ltd · TPEX:6986 | US$57.19M | US$32.04M | 16.2× | 3.4× | 6.5× | 1.8× | 37.7% | 0.0× | n/a |
| Median of the others | US$60.76M | US$43.45M | 16.2× | 4.9× | 6.5× | 2.2× | −20.8% | 0.1× | 1.28 |
Team and board
| Officer | Role |
|---|---|
| Jaehyun Choi | Executive, CEO |
| Sungjune Hong | Executive, CEO |
| Jongsoo Lee | Investor Relations |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Aug 18, 2026 | −5.3% |
| Q1 2026 | May 18, 2026 | −10.9% |
| Q4 2025 | Mar 18, 2026 | −5.0% |
| Q3 2025 | Nov 14, 2025 | −5.1% |
| Q2 2025 | Aug 29, 2025 | −7.7% |
| Q1 2025 | May 12, 2025 · After close | +1.6% |
| Q4 2024 | Mar 13, 2025 | −0.8% |
| Q3 2024 | Nov 12, 2024 · After close | −4.3% |
| Q2 2024 | Aug 13, 2024 · After close | +2.5% |
| Q1 2024 | May 14, 2024 · After close | +0.6% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 28, 2024 · Before open | −2.5% |
| Q3 2023 | Nov 14, 2023 · After close | +1.9% |
| Q2 2023 | Aug 14, 2023 · After close | +0.6% |
| Q1 2023 | May 15, 2023 · After close | −2.7% |
| Q4 2022 | Feb 10, 2023 · After close | −1.5% |
| Q3 2022 | Nov 14, 2022 · After close | +7.0% |
| Q2 2022 | Aug 16, 2022 · After close | −4.8% |
| Q1 2022 | May 16, 2022 · After close | +0.3% |
| Q4 2021 | Mar 17, 2022 · After close | +1.7% |
| Q3 2021 | Nov 15, 2021 · After close | −0.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2023) | Investor deck | 30 slides | January 2023 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.57B | 2.93B | 4.43B | 16.1B | 36.8B | 18.5B | 11.3B | 12.9B | 28.5B | 11.4B |
| Cost of revenue | 4.96B | 4.17B | 4.04B | 4.78B | 5.02B | 6.87B | 3.85B | 6.33B | 10.7B | 4.78B |
| Gross profit | -385.7M | -1.24B | 387.5M | 11.4B | 31.8B | 11.7B | 7.45B | 6.55B | 17.8B | 6.57B |
| Research and development | 26.6B | 22.0B | 26.3B | 26.4B | 33.1B | 39.2B | ||||
| Selling, general and administrative | 3.85B | 12.5B | 13.7B | 17.0B | 16.5B | 10.6B | 10.7B | 11.2B | 8.98B | 16.5B |
| Operating income | -36.1B | -36.9B | -42.4B | -34.5B | -20.2B | -46.6B | -44.5B | -38.2B | -26.9B | -30.9B |
| Depreciation and amortization | 7.03B | 4.37B | 4.63B | 4.87B | 3.30B | 2.92B | 2.50B | 1.65B | 2.03B | 2.21B |
| EBITDA | -29.0B | -32.6B | -37.8B | -29.6B | -16.9B | -43.7B | -42.0B | -36.5B | -24.9B | -28.7B |
| Interest expense | 2.44B | 2.65B | 4.11B | 3.31B | 492.4M | 2.92B | 0 | 0 | 0 | 0 |
| Income before tax | -27.2B | -65.4B | -66.9B | -57.1B | -48.6B | 27.5B | -16.5B | -34.1B | -19.3B | -30.9B |
| Net income | -27.2B | -63.7B | -66.9B | -56.3B | -47.7B | 27.6B | -16.5B | -34.1B | -19.3B | -30.9B |
| Earnings per share, basic | -598.40 | -1,400.75 | -1,613.36 | -1,721.54 | -1,382.80 | 1,116.28 | -694.79 | -1,209.39 | -698.54 | -1,260.91 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9.15B | 1.16B | 6.03B | 17.9B | 27.8B | 5.21B | 19.1B | 57.0B | 11.8B | 24.5B |
| Short-term investments | 25.8B | 30.9B | 58.5B | 4.00B | 0 | 1.50B | 63.5B | 115.3B | 36.9B | |
| Receivables | 300.3M | 4.78B | 10.7B | 9.38B | 1.03B | 2.74B | 3.96B | 2.49B | 14.7B | 5.60B |
| Inventory | 3.12B | 3.81B | 12.0B | 7.17B | 128.6M | |||||
| Current assets | 45.9B | 46.9B | 92.2B | 52.4B | 43.8B | 20.6B | 95.8B | 177.5B | 28.9B | 71.9B |
| Property, plant and equipment | 118.9B | 114.2B | 110.9B | 112.0B | 71.9B | 49.8B | 47.2B | 41.3B | 23.6B | |
| Total assets | 371.3B | 345.0B | 376.6B | 388.8B | 636.9B | 596.9B | 358.2B | 374.8B | 140.7B | 198.7B |
| Current liabilities | 116.9B | 54.0B | 54.5B | 78.9B | 59.2B | 40.2B | 22.6B | 10.8B | 13.0B | 26.1B |
| Long-term debt | 6.56B | 27.1B | 22.7B | 18.5B | 40.6B | 15.8B | 28.9B | 34.6B | 11.5B | 0 |
| Total debt | 26.0B | 29.2B | 34.6B | 14.5B | ||||||
| Total liabilities | 124.5B | 83.4B | 79.7B | 112.6B | 119.1B | 61.3B | 61.3B | 54.3B | 26.8B | 28.5B |
| Shareholders' equity | 246.8B | 261.7B | 296.6B | 276.2B | 517.7B | 535.6B | 296.9B | 320.5B | 113.9B | 170.2B |
| Shares outstanding | 45.5M | 45.5M | 41.4M | 32.7M | 34.5M | 24.7M | 23.8M | 28.2M | 27.7M | 24.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -29.6B | -1.65B | -38.1B | -39.8B | -12.7B | -22.7B | -41.6B | -20.1B | -26.1B | -14.1B |
| Capital spending | -14.8B | -7.30B | -7.38B | -31.7B | -56.4B | -22.2B | -3.96B | -8.01B | -20.5B | -5.07B |
| Free cash flow | -44.3B | -8.95B | -45.4B | -71.6B | -69.8B | -46.8B | -45.5B | -28.1B | -46.6B | -19.2B |
| Cash from investing | -11.2B | -34.3B | -1.92B | -7.70B | -64.4B | 1.64B | -185.6B | 17.8B | -53.6B | |
| Cash from financing | 7.96B | 60.4B | 31.6B | 43.1B | 73.4B | 3.33B | 250.9B | -3.64B | 81.1B | |
| Share buybacks | 84.2B | 1.98B | 13.4B | 61.9B | 3.50B | 206.2B | 4.06B | 61.4B | ||
| Change in cash | 7.99B | -4.87B | -11.9B | -9.85B | 22.6B | -13.9B | -36.6B | 45.2B | -12.0B | 13.4B |
Cap table
Built by 6ix from Genexine, Inc.’s releases
- Common shares
- 45,479,667
- Fully diluted
- 45,479,667
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 45,479,667 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 45,479,667 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jaehyun Choi | Executive, CEO · Since at least Sep 15, 2026 |
| Jongsoo Lee | Investor Relations · Since at least Sep 15, 2026 |
| Sungjune Hong | Executive, CEO · Since at least Nov 6, 2026 |
Log in to ask 6ix AI your own questions about Genexine, Inc.